Major Prediabetes Companies in India | Key Players 2026

Major Prediabetes Companies in India

The following is a data-backed list of the leading India Prediabetes companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the India Prediabetes Industry, including Cipla Limited, Sun Pharmaceutical Industries Limited, and other established names.

List of Prediabetes companies in India:

1. Cipla Limited

A global pharmaceutical pioneer, Cipla provides high-quality metabolic health solutions and essential medications that handle early-stage dysglycemia and diabetes management.

2. Sun Pharmaceutical Industries Limited

A major force in the chronic disease space, Sun Pharma focuses on research-driven metabolic treatments and wide-scale access to glucose-regulating therapies.

3. Torrent Pharmaceuticals Limited

A leading name in the cardiac-diabetic segment, Torrent offers advanced pharmacological options and a strong presence in blood sugar control and prevention.

4. Abbott India Limited

A global leader in diagnostic and monitoring services, Abbott provides advanced platforms that empower prediabetic individuals with real-time glucose data.

5. Mankind Pharma Limited

Focuses on affordability and reach, delivering reliable, high-volume pharmaceutical products that support mass-market prediabetes care across the country.

6. Dr. Reddy’s Laboratories Limited

Combines pharmaceutical excellence with patient-centric care, offering a range of therapeutic options for individuals aiming to delay the onset of type 2 diabetes.

7. Lupin Limited

A trusted player in chronic therapy, Lupin focuses on accessible and high-quality medication regimes designed for long-term health maintenance.

8. Zydus Lifesciences Limited

Part of the global health ecosystem, this brand focuses on high-precision research and the development of cost-effective metabolic care products.

9. Glenmark Pharmaceuticals Limited

Leverages global experience to provide a wide array of treatments for endocrine disorders and metabolic syndrome tailored for the Indian corporate and clinical sector.

10. Emcure Pharmaceuticals Limited

Provides robust pharmaceutical support for metabolic health, catering to the evolving needs of the modern Indian patient demographic.

Frequently Asked Questions About the Market Study (FAQs):